Department of Biological Sciences, Center for Stem Cells and Regenerative Medicine, Center for Zebrafish Research, Boler-Parseghian Center for Rare and Neglected Diseases, Warren Center for Drug Discovery, University of Notre Dame, Notre Dame, IN 46556, USA.
Cells. 2023 Feb 20;12(4):666. doi: 10.3390/cells12040666.
Despite significant advances in understanding nephron segment patterning, many questions remain about the underlying genes and signaling pathways that orchestrate renal progenitor cell fate choices and regulate differentiation. In an effort to identify elusive regulators of nephron segmentation, our lab conducted a high-throughput drug screen using a bioactive chemical library and developing zebrafish, which are a conserved vertebrate model and particularly conducive to large-scale screening approaches. 17β-estradiol (E2), which is the dominant form of estrogen in vertebrates, was a particularly interesting hit from this screen. E2 has been extensively studied in the context of gonad development, but roles for E2 in nephron development were unknown. Here, we report that exogenous estrogen treatments affect distal tubule composition, namely, causing an increase in the distal early segment and a decrease in the neighboring distal late. These changes were noted early in development but were not due to changes in cell dynamics. Interestingly, exposure to the xenoestrogens ethinylestradiol and genistein yielded the same changes in distal segments. Further, upon treatment with an estrogen receptor 2 (Esr2) antagonist, PHTPP, we observed the opposite phenotypes. Similarly, genetic deficiency of the Esr2 analog, , revealed phenotypes consistent with that of PHTPP treatment. Inhibition of E2 signaling also resulted in decreased expression of essential distal transcription factors, and its target . These data suggest that estrogenic compounds are essential for distal segment fate during nephrogenesis in the zebrafish pronephros and expand our fundamental understanding of hormone function during kidney organogenesis.
尽管人们对肾单位节段模式的认识有了显著的进展,但仍有许多问题尚未解决,例如决定肾祖细胞命运选择和调控分化的潜在基因和信号通路。为了鉴定肾单位分段的隐匿性调节因子,我们实验室利用生物活性化学文库和斑马鱼进行了高通量药物筛选,斑马鱼是一种保守的脊椎动物模型,特别适合大规模筛选方法。17β-雌二醇(E2)是脊椎动物中雌激素的主要形式,是该筛选中的一个特别有趣的靶点。E2 在性腺发育方面已经得到了广泛的研究,但 E2 在肾单位发育中的作用尚不清楚。在这里,我们报告外源性雌激素处理会影响远曲小管的组成,即导致远段早期段增加,而相邻的远段晚期段减少。这些变化在早期发育中就已经出现,但不是由于细胞动力学的变化。有趣的是,暴露于外源性雌激素乙炔雌二醇和金雀异黄素也会导致远段段发生相同的变化。此外,用雌激素受体 2(Esr2)拮抗剂 PHTPP 处理后,我们观察到相反的表型。同样,Esr2 类似物的基因缺失也表现出与 PHTPP 处理一致的表型。E2 信号的抑制也导致必需的远段转录因子和其靶基因的表达减少。这些数据表明,在斑马鱼前肾发生过程中,雌激素类化合物对于远段段的命运是必需的,这扩展了我们对激素在肾脏器官发生过程中功能的基本认识。